Skip to Main Content

Paper Details

Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.
J Acquir Immune Defic Syndr
12
2020
AIDS, CD4, HIV, IBA, Ibalizumab, MDR HIV, Multidrug-Resistant HIV, OBR, People, ibalizumab, patients, people, person
Author NameAffiliation
Paul E SaxBrigham and Women's Hospital
Rochelle P WalenskyMassachusetts General Hospital
Rochelle P WalenskyBrigham and Women's Hospital
Rochelle P WalenskyHarvard Medical School
Rochelle P WalenskyMassachusetts General Hospital
Rochelle P WalenskyMassachusetts General Hospital
Rochelle P WalenskyHarvard University Center for AIDS Research
Kenneth A FreedbergMassachusetts General Hospital
Kenneth A FreedbergHarvard Medical School
Kenneth A FreedbergMassachusetts General Hospital
Kenneth A FreedbergMassachusetts General Hospital
Kenneth A FreedbergHarvard University Center for AIDS Research
Kenneth A FreedbergHarvard T.H. Chan School of Public Health
  • 1 - 13

Datasets

Release 1.2